(Q44241974)

1 December 2017

title

Hepatitis A/B vaccination of adults over 40 years old: comparison of three vaccine regimens and effect of influencing factors (English)

1 reference

1 December 2017

1 reference

5

Frank von Sonnenburg

0 references

Pierre Van Damme

series ordinal

2

object named as

Pierre Van Damme

1 reference

1 December 2017

Marie Van der Wielen

1

1 reference

1 December 2017

Roman Chlibek

series ordinal

3

1 reference

1 December 2017

Jan Smetana

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

4 May 2006

1 reference

1 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

1 December 2017

volume

24

1 reference

1 December 2017

issue

26

1 reference

1 December 2017

page(s)

5509-5515

1 reference

Inactivated hepatitis A vaccine: immunogenicity, efficacy, safety and review of official recommendations for use.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Recombivax-HB: perspectives past, present and future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

The first combined vaccine against hepatitis A and B: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Immunogenicity of Twinrix in older adults: a critical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Hepatitis B vaccine responsiveness in Connecticut public safety personnel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Immunogenicity of a recombinant hepatitis B vaccine in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Antibody-response to three recombinant hepatitis B vaccines: comparative evaluation of multicenter travel-clinic based experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

The effect of age and weight on the response to formalin inactivated, alum-adjuvanted hepatitis A vaccine in healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Production of antibody to hepatitis A virus and hepatitis B surface antigen measured after combined hepatitis A/hepatitis B vaccination in 242 adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

The aging immune system: primary and secondary alterations of immune reactivity in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

The immune system in the elderly: I. Specific humoral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Immunogenicity of two recombinant hepatitis B vaccines in older individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Immunogenicity of combined hepatitis A and B vaccine in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Hepatitis A+B vaccine in elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

A breakthrough case of hepatitis A disease following a full vaccination schedule of three doses of a combined hepatitis A and B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Intramuscular or intralipomatous injections?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

Magnitude and quality of antibody response to a combination hepatitis A and hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.04.016

10.1016/J.VACCINE.2006.04.016

7 January 2021

Identifiers

DOI

1 reference

1 December 2017

1 reference